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Background: Notch1 is a potent regulator known to play an oncogenic role in many malignancies including T-cell
acute lymphoblastic leukemia (T-ALL). Tumor hypoxia and increased hypoxia-inducible factor-1α (HIF-1α) activity
can act as major stimuli for tumor aggressiveness and progression. Although hypoxia-mediated activation of the
Notch1 pathway plays an important role in tumor cell survival and invasiveness, the interaction between HIF-1α
and Notch1 has not yet been identified in T-ALL. This study was designed to investigate whether hypoxia activates
Notch1 signalling through HIF-1α stabilization and to determine the contribution of hypoxia and HIF-1α to
proliferation, invasion and chemoresistance in T-ALL.
Methods: T-ALL cell lines (Jurkat, Sup-T1) transfected with HIF-1α or Notch1 small interference RNA (siRNA) were
incubated in normoxic or hypoxic conditions. Their potential for proliferation and invasion was measured by WST-8
and transwell assays. Flow cytometry was used to detect apoptosis and assess cell cycle regulation. Expression and
regulation of components of the HIF-1α and Notch1 pathways and of genes related to proliferation, invasion and
apoptosis were assessed by quantitative real-time PCR or Western blot.
Results: Hypoxia potentiated Notch1 signalling via stabilization and activation of the transcription factor HIF-1α.
Hypoxia/HIF-1α-activated Notch1 signalling altered expression of cell cycle regulatory proteins and accelerated cell
proliferation. Hypoxia-induced Notch1 activation increased the expression of matrix metalloproteinase-2 (MMP2)
and MMP9, which increased invasiveness. Of greater clinical significance, knockdown of Notch1 prevented the
protective effect of hypoxia/HIF-1α against dexamethasone-induced apoptosis. This sensitization correlated with
losing the effect of hypoxia/HIF-1α on Bcl-2 and Bcl-xL expression.
Conclusions: Notch1 signalling is required for hypoxia/HIF-1α-induced proliferation, invasion and chemoresistance
in T-ALL. Pharmacological inhibitors of HIF-1α or Notch1 signalling may be attractive interventions for T-ALL
treatment.
Keywords: T-cell acute lymphoblastic leukemia, Hypoxia, HIF-1α, Notch1, Proliferation, Invasion, Chemoresistance* Correspondence: jichunyan@sdu.edu.cn
†Equal contributors
1Department of Hematology Qilu Hospital of Shandong University, Jinan,
Shandong, 107 West Wenhua Road, Jinan, Shandong 250012, People’s
Republic of China
Full list of author information is available at the end of the article
© 2013 Zou et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Zou et al. Journal of Hematology & Oncology 2013, 6:3 Page 2 of 13
http://www.jhoonline.org/content/6/1/3Background
T-cell acute lymphoblastic leukemia (T-ALL), which
accounts for 25% of cases of adult ALL, is characterized
by the malignant clonal expansion of immature T-cell
progenitors [1]. More than 50% of cases of T-ALL in-
volve somatic activating mutations of Notch1 [2], a po-
tent regulator known to play an oncogenic role in many
malignancies, affecting proliferation, invasion, chemore-
sistance, angiogenesis and cell fate determination [3-5].
In the Notch1 signalling pathway, Notch1 transmem-
brane receptors become activated when ligands bind to
their extracellular domains. This ligand binding results
in two consecutive proteolytic cleavage events that liber-
ate the intracellular Notch1 (ICN), which enters the nu-
cleus and interacts with the DNA-binding protein CSL
(CBF1/RBP-J, Su(H), Lag-1) to regulate expression of
downstream genes [6]. In murine models, constitutive
activation of Notch1 signalling induced T-ALL, demon-
strating the key role of Notch1 in the pathogenesis of T-
ALL [7]. Interference with aberrant Notch1 signalling in
the context of T-ALL has the potential to inhibit prolif-
eration and induce apoptosis, suggesting that Notch1
may be a pivotal oncogene [8,9].
In bone marrow, hematopoiesis occurs under relatively
hypoxic conditions [10]. Hypoxia induces cells to
undergo a variety of biological responses, including up-
regulation of a series of physiologically important genes
such as erythropoietin, glucose transporter type 1 and
vascular endothelial growth factor (VEGF) [11,12]. Acti-
vation of these hypoxia-induced genes enables cells to
respond to oxygen deprivation by modifying cell growth,
metabolism, erythropoiesis and angiogenesis. Hypoxia-
inducible factor-1 (HIF-1), a heterodimeric transcription
factor consisting of HIF-1α and HIF-1β subunits, plays a
critical role in cellular response to hypoxic conditions. It
is well established that HIF-1α is the unique, O2-regu-
lated subunit that determines HIF-1 activity [13]. Tumor
hypoxia and increased HIF-1α activity can act as major
stimuli for tumor aggressiveness and progression [14].
Hypoxia may also play a pivotal role in chemoresistance
after leukemic chemotherapy. Severely hypoxic areas of
bone marrow contain leukemic stem cells (LSCs) re-
sponsible for minimal residual disease [15,16], which
results in hematologic relapse and may serve as a marker
for chemoresistance [17-19]. Moreover, it has been
shown that Notch signalling is augmented under hyp-
oxic conditions in human cervical, colon, ovarian and
breast cancer cell lines. These reports seem to implicate
activation of the hypoxia-mediated Notch pathway in
tumor cell survival and invasiveness [5,20].
We down-regulated HIF-1α and Notch1 using small
interference RNA (siRNA) in order to elucidate the in-
fluence of Notch1 signalling in hypoxia and also to as-
sess the effect of hypoxia on T-ALL proliferation,invasion and chemoresistance. We provide evidence that
hypoxia-induced proliferation, invasion and chemoresis-
tance of T-ALL cells are dependent on HIF-1α-induced
functional activation of Notch1 signalling.
Methods
Reagents
Primary antibodies for HIF-1α and Hes1 were purchased
from Abcam (Cambridge, UK), and those for Notch1
ICN, Cyclin D1, cyclin-dependent kinase 2 (CDK2), p21,
MMP2, MMP9, Bcl-2, Bcl-xL, cleaved caspase-3, cleaved
caspase-9 and poly (ADP)-ribose polymerase (PARP)
were purchased from CST (Beverly, MA). The primary
antibody for β-Actin and all secondary antibodies were
obtained from Zhongshan Golden Bridge Biotech (Shen-
zhen, China). Sources of other reagents are indicated in
the text.
Cell culture and hypoxia
Jurkat and Sup-T1 cells were cultured in RPMI 1640
medium supplemented with 10% (v/v) heat-inactivated
fetal bovine serum (FBS, Gibco, Grand Island, NY), 100
U/ml penicillin and 100 mg/ml streptomycin (Invitro-
gen, Carlsbad, CA) in an incubator maintained at 37°C
in an atmosphere containing 5% CO2 and air.
Hypoxic conditions were achieved by culturing cells in a
sealed, anaerobic work station (Concept 400, Ruskin
Technologies, Pencoed, Wales, UK), in which the hypoxic
environment (2% O2, 93% N2 and 5% CO2), temperature
(37°C), and humidity (90%) was kept constant.
RNA interference
The following double-strand RNA oligos specific for
HIF-1α (50-GUUGCCACUUCCACAUAAUTT-30) and
Notch1 (50-UACAGUACUGACCUGUCCACUCUGG-30)
were synthesized by Shanghai GenePharma (Shanghai,
China). Commercially available siRNA to random noncoding
sequences were used for control transductions (Shanghai
GenePharma). To obtain HIF-1α or Notch1 knock-down
cells with transient transfection, cells were transfected with
siRNA duplexes at the final concentration of 100 nM using
Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA).
Hes1 promoter luciferase assay
The luciferase assay was performed with a Notch dual-
luciferase assay kit (Qiagen, Valencia, USA) following
the manufacturer’s instructions. Briefly, cells (3 × 104
cells/well in a 96-well plate) were transfected with a
RBP-Jκ responsive firefly luciferase reporter together
with an expression vector of Renilla luciferase using
Lipofectamine LTX and Plus™ Reagent (Invitrogen).
After 12 h, cells were washed and then cultured under
hypoxic conditions for 48 h. The luciferase assay was
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using Renilla luciferase as an internal control.
Proliferation assay
The effect of hypoxia on the viability of T-ALL cells was
evaluated by 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophe-
nyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, a monosodium
salt (WST-8) assay (Dojindo Molecular Technologies,
Tokyo, Japan). Briefly, cells were seeded at a density of
5 × 103 cells per well in 96-well microplates and placed in
the hypoxic incubator for 24 h, 48 h or 72 h, 10 ul WST-8
solution was applied to each well and they were incubated
for 4 h at 37°C. Absorbance was measured at 450 nm
using a microplate reader (Benchmark Microplate Reader,
BIO-RAD) with a reference wavelength of 655 nm.
Cell cycle distribution analysis
For cell cycle analysis, T-ALL cells were plated on 6-well
plates and cultured under hypoxic conditions for 48 h.
Cells were fixed in 70% alcohol for 1 h at 4°C, resuspended
with propidium iodide (PI) solution (0.04 mg/ml) contain-
ing 0.2 mg/ml RNase A (both from Sigma-Aldrich, St.
Louis, USA), and incubated at room temperature in the
dark for 30 min. DNA content was then analyzed using
FACS Calibur (Becton Dickinson, CA, USA).
Drug treatment under hypoxic conditions
Jurkat and Sup-T1 cells were incubated for 24 h under
hypoxic conditions, with a pulse of 1 μM dexamethasone
(Sigma-Aldrich, St. Louis, USA) added for 48 h under
continuous hypoxic conditions. Cells were collected for
the apoptosis assay and Western analysis of Bcl-2, Bcl-xL,
cleaved caspase-3, cleaved caspase-9 and cleaved PARP.
Apoptosis assay
The apoptosis assay was performed using an Annexin V/PI
Apoptosis Detection Kit (Jingmei Biotech, Shenzhen,
China). Cells were harvested, resuspended in 100 μl of
binding buffer, labeled with 5 μl Annexin V-biotin followed
by 10 μl PI and incubated for 15 min in the dark. Then
400 μl binding buffer was added and Annexin V-PI was
measured by FACS Calibur (Becton Dickinson, CA, USA).
RNA extraction and quantitative real-time PCR
Total RNA was prepared from cell lines using TRIzol
reagent (Takara, Dalian, China) according to the manu-
facturer’s protocol. For reverse transcription, double-
stranded cDNA was synthesized from about 1 μg of total
RNA using M-MLV RTase cDNA Synthesis Kit (Takara).
Quantitative real-time PCR (qRT-PCR) was performed
using a LightCycler 2.0 Instrument (Roche, Penzberg,
Germany) with SYBR Green PCR Master Mix (Toyobo,
Osaka, Japan). Samples were run in triplicate and ampli-
fied in a 20 μl reaction according to the manufacturer’sexperimental protocol. The housekeeping gene β-Actin,
which has relatively constant expression in T-ALL cell
lines, was used as an internal control. Primer sequences
were as follows (50-30): Notch1 forward: GGG TCC ACC
AGT TTG AAT GG; Notch1 reverse: GTT TGC TGG
CTG CAG GTT CT; Hes1 forward: TGA TTT GGA
TGC TCT GAA GAA AGA TA; Hes1 reverse: GCT
GCA GGT TCC GGA GGT; HIF-1α forward: TTT
GCT GAC ACA GAA GCA AAG A; HIF-1α reverse:
TTG AGG ACT TGC GCT TTC AGG; VEGF forward:
GAG CCT TGC CTT GCT GCT CTA C; VEGF reverse:
CAC CAG GGT CTC GAT TGG ATG; MMP2 forward:
CAG GGA ATG AAT ACT GGA TCT ACT; MMP2 re-
verse: GCT CCA GTT AAA GGC GGC ATC CAC;
MMP9 forward: GCC TGC AAC GTG AAC ATC T;
MMP9 reverse: TCA AAG ACC GAG TCC AGC TT; β-
Actin forward: CGG GAC CTG ACT GAC TAC CT; β-
Actin reverse: AAG CAT TTG CGG TGG A.
Western blot
Cells were harvested in ice-cold RIPA lysis buffer in the
presence of the protease inhibitor phenylmethylsulfonyl
fluoride (both from Beyotime, Haimen, China) for
30 min, and lysates were cleared by centrifugation. Pro-
tein concentrations in the supernatant were quantified
with the bicinchoninic acid assay protein reagent kit
(Sangon, Shanghai, China) according to a standardized
curve. Proteins were fractionated by sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis and transferred
onto polyvinylidene fluoride membranes. Non-specific
sites were blocked with 5% nonfat milk in PBS/0.1% Tri-
ton X-100 and incubated with appropriate primary anti-
bodies overnight at 4°C, followed by incubation with
horseradish peroxidase conjugated anti-mouse or anti-
rabbit IgG at room temperature for 1 h. After washing,
immunoreactive bands were detected by enhanced
chemiluminescence (Millipore, Billerica, MA).
Transwell invasion assay
The invasive potential of T-ALL cells was examined using
transwell inserts fitted with polycarbonate filters (5 um
pore size, Costar, Cambridge, MA) coated with matrigel
(BD Biosciences, Bedford, MA). Matrix solutions within
transwells were polymerized at 37°C for 1 h and dried
onto the transwells overnight at room temperature. Cells
in FBS-free medium were seeded in the upper compart-
ment while lower wells contained 10% FBS medium. After
48 h of hypoxic incubation, the cells in the upper chamber
were removed while other cells, which had passed through
the filter on the underside of the membrane, were fixed
with 3.7% paraformaldehyde, stained with 0.2% crystal vio-
let, counted and captured at 100× and 400× magnification
using the camera on inverted microscope. Contents of the
lower compartments were collected and migrated cells
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the fraction of migrated cells out of the total number of
cells placed in the upper compartment.
Statistical analysis
Experiments were performed three times and data are
expressed as mean ± SD. Statistical analysis was con-
ducted using Student’s t-test. Unless otherwise specified,
P < 0.05 was considered significant.
Results
Hypoxia induced accumulation of HIF-1α in T-ALL cells
Constitutive expression of HIF-1α has been reported in
many malignant human cells in vitro under normoxic
conditions [21]. Normally, HIF-1α protein steadily
increases in nuclei when cells are exposed to hypoxia
but rapidly undergoes von Hippel–Lindau protein-
mediated proteasomal degradation in the presence of
oxygen [13]. Therefore, expression of HIF-1α transcrip-
tion factor is regulated at the level of protein by hypoxia.
We confirmed these results in T-ALL cells by showing
that HIF-1α protein was constitutively expressed in the
nucleus in vitro under normoxic conditions, with a fur-
ther increase in HIF-1α protein but not HIF-1α mRNA
under hypoxic conditions (Figure 1A-B). To test whether
HIF-1α signalling was activated in hypoxia, we measured
expression of the HIF-1α downstream target gene VEGF
and found that expression of VEGF and HIF-1α
increased concurrently (Figure 1A).
Hypoxia and HIF-1α potentiated Notch1 signalling
To address whether hypoxia activates Notch1 in T-ALL
cells, we investigated whether exogenous modulation of
the Notch1 pathway in T-ALL cells was regulated differ-
ently in hypoxia than in normoxia. We found that total
Notch1, activated Notch1 (Notch1 ICN) and Hes1
(a Notch1 target gene), components of the Notch1 pathway,
were up-regulated in hypoxic conditions (Figure 1A-B).
These results confirmed that the Notch1 pathway was more
strongly activated in hypoxia than in normoxia. Analysis of
Notch1 transcriptional activity using an in vitro luciferase
reporter assay revealed a significant increase in Notch1
activity when T-ALL cells were exposed to hypoxic condi-
tions (Figure 1C).
Notch1 activation in hypoxia is HIF-1α-dependent
As demonstrated above, expression of the Notch1 target
gene Hes1 was elevated under hypoxic conditions. This
indicates that hypoxia enhances Notch1 activity, result-
ing in increased transcription of genes downstream from
Notch1. To evaluate whether HIF-1α contributes to acti-
vation of hypoxia-induced Notch1 signalling, we used
siRNA to silence endogenous gene expression of HIF-1α
and Notch1. Under hypoxic conditions, silencing HIF-1αinhibited Notch1 signalling, as shown by decreased ex-
pression of Notch1, Notch1 ICN and Hes1, whereas si-
lencing Notch1 did not affect HIF-1α expression
(Figure 1D-E). (The effectiveness of the siRNAs designed
to silence HIF-1α and Notch1 in these T-ALL cells is
shown in Figure 2). These data demonstrate that
hypoxia-induced Notch1 signalling activation is due to
increased HIF-1α accumulation.
Hypoxia and HIF-1α may potentially promote
proliferation of T-ALL cells via activation of the Notch1
signalling pathway
To observe the effects of hypoxia and HIF-1α on growth
of T-ALL cells, cell proliferation assays were performed
at baseline and after 24 h, 48 h and 72 h exposure to
hypoxia. As shown in Figure 3A, 2% hypoxia for 72 h
led to consistently accelerated cell growth compared
with normoxic conditions. We next investigated whether
accelerated proliferation is mediated through regulation
of the cell cycle. As shown in Figure 3B-C, 48 h expos-
ure to hypoxia substantially reduced the number of cells
in the G0/G1 phase of the cell cycle while concomitantly
increasing the number of cells in the S and G2/M
phases. The effect of hypoxia on cell cycle regulatory
molecules operative in the G1 phase was further exam-
ined. Hypoxia reduced expression of p21 protein, the
key regulator of the G1-S phase transition, while increas-
ing protein expression of Cyclin D1 and CDK2 in T-ALL
cells (Figure 3D). These results provide evidence that
hypoxia promotes proliferation of T-ALL cells by redu-
cing the number of cells in the G0/G1 phase of the cell
cycle. To determine whether hypoxia-promoted cell pro-
liferation was mediated by accumulation of HIF-1α, we
knocked down HIF-1α expression under hypoxic condi-
tions, which significantly reduced cell growth (P < 0.01,
Figure 4A). A decreased rate of proliferation was further
demonstrated by cell cycle analysis, which showed that
silencing HIF-1α increased the proportion of cells in the
G0/G1 phase compared with control (Figure 4B-C).
When expression of G0/G1 phase cell cycle regulatory
proteins was evaluated, we found that silencing HIF-1α
reduced protein levels of CDK2 and Cyclin D1 while
markedly elevating protein expression of p21 compared
with control (Figure 4D).
To test whether hypoxia and HIF-1α promote prolif-
eration of T-ALL cells via activation of the Notch1 sig-
nalling pathway, we silenced Notch1 signalling in T-ALL
cells using Notch1 siRNA under hypoxic conditions. A
viability assay showed that, after 72 h hypoxia, the num-
ber of Notch1 knockdown cells was significantly smaller
than the number of control cells (P < 0.01, Figure 4A).
This result is consistent with data from cell cycle ana-
lysis, which detected a marked G0/G1 phase arrest when
Notch1 was silenced (Figure 4B-C). These experiments
Figure 1 Hypoxia potentiated Notch1 signalling via stabilization and activation of transcription factor HIF-1α. Expression of components
of the HIF-1α and Notch1 signalling pathways at the mRNA (A) and protein (B) levels in Jurkat and Sup-T1 cells cultured under hypoxic
conditions for 48 h. (A) Results normalized to β-Actin are calibrated to a normoxic control and presented as relative mRNA expression level. *, P <
0.01. (B) N, normoxia group; H, hypoxia group. Results shown are representative of at least three independent experiments. (C) Notch1-luciferase-
transfected Jurkat cells had significantly greater reporter gene activity when incubated in hypoxic conditions for 48 h than in normoxia. Results
are calibrated to normoxic control. RLU, relative light units. *, P < 0.01. Components of the HIF-1α and Notch1 signalling pathways were assayed
by qRT-PCR (D) and Western Blot (E) to determine the effect of knocking down HIF-1α or Notch1 expression in hypoxia. Notch1 signalling was
inhibited by HIF-1α blockage, whereas HIF-1α expression was not affected by Notch1 suppression. HS, HIF-1α siRNA-transfected group; NS,
Notch1 siRNA-transfected group; CS, control siRNA-transfected group. *, P < 0.01.
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in hypoxia reduces growth of T-ALL cells through in-
duction of G0/G1 phase arrest. This conclusion is fur-
ther supported by the protein expression pattern when
Notch1 signalling is silenced under hypoxic conditions,
in which CDK2 and Cyclin D1 were inhibited while p21
was increased (Figure 4D). These results indicate that
increased Notch1 expression in hypoxic T-ALL cells
drives cell proliferation by reducing the proportion of
cells in the G0/G1 phase of the cell cycle.
Hypoxia/HIF-1α-induced T-ALL cell invasion and MMP2/9
up-regulation require Notch1 signalling
To examine whether hypoxia could influence the ability
of T-ALL cells to activate proinvasive protease cascades,
Jurkat and Sup-T1 cells were evaluated in an invasion
assay using transwell matrigel-coated chambers. Wecultured both cell lines under hypoxic conditions and
found that hypoxia transcriptionally up-regulated MMP2
and MMP9, and induced morphological changes typical
of higher invasiveness, such as increased penetration
through the matrigel-coated membrane (Figure 5). To
evaluate whether HIF-1α mediates hypoxia-induced
higher invasiveness, we silenced HIF-1α with specific
siRNA. As illustrated in Figure 6, the increased expression
of MMP2 and MMP9 induced by hypoxia was attenuated
in HIF-1α knockdown cells. These results demonstrate
that hypoxia/HIF-1α promotes T-ALL invasion by tran-
scriptionally up-regulating MMP2 and MMP9.
Because hypoxia/HIF-1α promoted the activation of
Notch1 and MMP2/9, and MMP2/9 genes are down-
stream from Notch1, we assessed whether hypoxia/HIF-
1α up-regulated MMP2/9 through a Notch1-dependent
mechanism. In these assays, inhibition of Notch1
Figure 2 HIF-1α and Notch1 expression are down-regulated in T-ALL cells transfected with specific siRNA. Jurkat and Sup-T1 T-ALL cells
were transfected with HIF-1α siRNA, Notch1 siRNA or control siRNA and cultured under normoxic conditions. (A) qRT-PCR shows mRNA levels of
HIF-1α and Notch1, normalized to β-Actin and presented as relative mRNA expression level. *, P < 0.01. Results are an average of three
independent experiments. (B) Western blot analysis of HIF-1α and Notch1 ICN expression in Jurkat and Sup-T1 cells transfected with HIF-1α or
Notch1 siRNA. Results shown are representative of at least three independent experiments.
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MMP9 observed during hypoxia (Figure 6), and higher
invasiveness was also abrogated, providing additional
evidence that hypoxia/HIF-1α-induced MMP2/9 up-
regulation in T-ALL cells requires Notch1 signalling.
Notch1 signalling is required for hypoxia/HIF-1α-induced
T-ALL chemoresistance
To clarify whether hypoxia induces chemoresistance of
T-ALL cells, Jurkat and Sup-T1 cells were treated with
1 μM dexamethasone in normoxic or hypoxic conditions
for 48 h and subjected to apoptosis analysis. The propor-
tion of apoptotic cells was significantly lower in hypoxia
than in normoxia (P < 0.01), indicating that hypoxia
resulted in significant resistance to dexamethasone in T-
ALL cells (Figure 7A-B).
We next assessed the effect of hypoxia on anti-
apoptotic proteins, including the Bcl-2 family of anti-
apoptotic proteins that plays a central role in establish-
ing the threshold for apoptosis. As shown in Figure 7C,
Western blot analysis of lysates derived from T-ALL
cells subjected to dexamethasone treatment in hypoxia
revealed increased expression of both Bcl-2 and Bcl-xL.
Given that caspase activation has been suggested to play
an important role in apoptosis, we ascertained the ex-
pression of active fragments of caspases under the same
conditions. Hypoxia provoked a significant decrease in
levels of the active products of caspase 3 and caspase 9,
at the same time that levels of cleaved PARP, the sub-
strate of caspase 3, dropped sharply. These results sug-
gest that hypoxia induced chemoresistance of T-ALLcells by up-regulating Bcl-2 and Bcl-xL, which resulted
in decreased dexamethasone-induced apoptosis of T-
ALL cells through the intrinsic pathway.
We next ascertained whether hypoxia-induced che-
moresistance was mediated by HIF-1α overexpression.
HIF-1α-siRNA-transfected cells showed a significantly
higher rate of cell death after dexamethasone treatment
than control cells (Figure 8A-B). Moreover, down-
regulation of HIF-1α decreased expression of Bcl-2 and
Bcl-xL and abrogated hypoxia-induced decreased cas-
pase 3 and caspase 9 activity (Figure 8C).
It has been proposed that knockdown of Notch1 sig-
nalling with a γ-secretase inhibitor can reverse gluco-
corticoid resistance in T-ALL [10], implicating Notch1
activation in chemoresistance. As shown in Figure 8A-B,
down-regulation of Notch1 effectively impaired cell via-
bility in hypoxia and increased the proportion of apop-
tosis induced by dexamethasone. Western blot analysis
of Notch1 siRNA-transfected cells showed a marked de-
crease in Bcl-2 and Bcl-xL at the same time that levels
of activated caspase 9 and caspase 3 as well as cleaved
PARP all increased, indicating activation of apoptosis
(Figure 8C). These results provide evidence that Notch1
signalling is required for hypoxia/HIF-1α-mediated
chemoresistance.
Discussion
There is increasing evidence that tumor cells often res-
ide in a low oxygen tension environment that promotes
accumulation of HIF-1α and is involved in tumor pro-
gression and aggressiveness. However, the effect of
Figure 3 Hypoxia promotes proliferation of T-ALL cells by reducing the G0/G1 phase of the cell cycle. (A) Jurkat and Sup-T1 cells were
cultured in hypoxia for up to 72 h, causing increased cell growth compared with normoxia. *, P < 0.01. Results are an average of three
independent experiments. (B) After exposure to normoxia (a, c) or hypoxia (b, d) for 48 h, T-ALL cells were stained with PI and analyzed for their
DNA content using FACS Calibur. The percentage of cells in G1/G0, S and G2/M in each group is shown in (C). *, P < 0.01. Data plotted are mean
± SD of three separate experiments. (D) Representative Western blot of cell cycle regulators Cyclin D1, CDK2 and p21 in cells cultured under
hypoxic conditions for 48 h. Results shown are representative of at least three independent experiments.
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isms by which hypoxia exerts its effects are still not
clear. Notch1 signalling has been shown to play an
oncogenic role in the majority of hematological malig-
nancies including T-ALL. Further, Notch1 is related to
resistance to chemotherapy, a major cause of treatment
failure and poor prognosis in T-ALL. Hypoxia-induced
expression of Notch receptors and ligands has been
demonstrated in stem cells and malignant tumors
[22,23]. In the present study, we showed that Notch1
signalling was activated by hypoxia and its transducer
HIF-1α. Furthermore, we provide the first evidence that
hypoxia/HIF-1α promoted the progression of T-ALL
through activation of the Notch1 pathway, resulting in
altered expression of downsteam genes regulating cellu-
lar proliferation, invasion and chemoresistance. HIF-1α-
dependent overexpression of Notch1 in T-ALL cells is
one of the major mechanisms underlying T-ALL aggres-
siveness and resistance to chemotherapy.
The role of hypoxia and HIF-1α in cellular proliferation
has been investigated in various cell types. It has been
revealed that hypoxia and HIF-1α convey stimulating orinhibiting effects on cellular proliferation and viability, de-
pending on cell type. Studies on epithelial ovarian tumors
and esophageal cancer showed that HIF-1α overexpres-
sion correlated with tumor apoptosis and patient survival
[24,25]. However, in an animal model of chronic myeloid
leukemia (CML), inhibition of HIF-1α impaired propaga-
tion of CML by impairing cell cycle progression and indu-
cing apoptosis of LSCs, suggesting that HIF-1α plays a
crucial role in survival maintenance of LSCs [26]. In the
current study, we showed that hypoxia and HIF-1α, by re-
ducing the proportion of cells in the G0/G1 phase of the
cell cycle, promote the proliferation of T-ALL cells. Mo-
lecular investigation revealed that, under hypoxic condi-
tions, expression of Cyclin D1 and CDK2 was increased
whereas p21 expression was decreased. We also found
that Notch1 ICN was augmented by hypoxia and this ef-
fect was dependent on HIF-1α accumulation, consistent
with previous results [23]. Potentiation of Notch1 signal-
ling by hypoxia was further corroborated by elevated ex-
pression of the Notch1 downstream gene Hes1 in hypoxic
conditions. Inhibition of Notch1 activity using Notch1-
targeted siRNA reversed hypoxia-induced changes in
Figure 4 Hypoxia/HIF-1α may potentially promote proliferation of T-ALL cells via activation of the Notch1 signalling pathway. (A)
Knockdown of HIF-1α or Notch1 expression significantly inhibited cell proliferation in hypoxic conditions. *, P < 0.01. Data plotted are mean ± SD
of three separate experiments. (B) Similarly, cell cycle analysis showed a higher proportion of cells in the G0/G1 phase when HIF-1α or Notch1 is
silenced compared with control. The percentage of cells in G1/G0, S and G2/M in each group is shown in (C). *, P < 0.01. Data plotted are mean
± SD of three separate experiments. (D) Representative Western blot analyses of G0/G1 phase cell cycle regulatory proteins in transfected cells
cultured in hypoxia for 48 h.
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Figure 5 Hypoxia promoted T-ALL invasion by transcriptionally up-regulating MMP2 and MMP9. (A) 104 cells were seeded onto matrigel-
coated transwell inserts and allowed to migrate through the filter in normoxia or hypoxia for 48 h. Migrated cells were fixed, stained and
captured at 100× and 400× magnification using the camera on an inverted microscope. (B) The total number of migrated cells was counted
manually. Results shown are expressed as a percentage of control invasion. *, P < 0.01. Data plotted are mean ± SD of three separate experiments.
(C) qRT-PCR showed that MMP2 and MMP9 were transcriptionally up-regulated in Jurkat and Sup-T1 cells kept in hypoxia for 48 h. The results
normalized to β-Actin are presented as relative expression level. *, P < 0.01. Data plotted are mean ± SD of three separate experiments.
(D) Western blot showing up-regulated protein levels of MMP2 and MMP9 in hypoxia. Results shown are representative of at least three
independent experiments.
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http://www.jhoonline.org/content/6/1/3expression of cell cycle regulatory proteins (CDK2,
CyclinD1 and p21), thus repressed the hypoxia-induced
proliferation of T-ALL cells. On the basis of these results,
we concluded that hypoxia potentiated Notch1 signalling
in T-ALL, leading to altered expression of cell cycle regu-
latory proteins and increased cell proliferation.
T-ALL is characterized as leukemic cell infiltration of
various organs such as lymph nodes, liver, spleen and
lungs. MMPs, in particular the gelatinases MMP2 and
MMP9, are an important group of zinc- and calcium-
dependent proteolytic enzymes responsible for degradation
of the vascular basement membrane and the extracellular
matrix of lymphoid tissues [27]. A previous study sug-
gested that hypoxia and HIF-1α overexpression contribute
to tumor cell invasion and dissemination, probably through
activation of MMPs [28]. Considerable evidence has accu-
mulated that MMP9 and MMP2 play an important role inthe invasiveness and propagation of several hematological
malignancies [29-31]. Our studies indicate that hypoxia
may be an initiating event that results in enhanced Notch1
signalling, increased expression of MMP2 and MMP9, and
ultimately increased invasiveness of T-ALL. Furthermore,
inhibition of Notch1 signalling abrogated hypoxia/HIF-1α-
induced cell invasion, probably through down-regulation
of MMP2 and MMP9. This indicates that Notch1 may
serve as a critical intermediary that transforms the hypoxic
response into invasion.
In addition to cellular invasion, as discussed above,
chemoresistance has been recognized as another major
cause of treatment failure among patients who suffer
from T-ALL. Previous studies have shown that hypoxia
is closely related to tumor resistance to anticancer ther-
apy in a wide spectrum of neoplastic cells [32,33]. We
hypothesized that chemoresistance to dexamethasone,
Figure 6 Hypoxia/HIF-1α-induced T-ALL cell invasion and MMP2/9 up-regulation require Notch1 signalling. (A) Representative 400×
magnification fields in invasion assay of HIF-1α or Notch1 siRNA transfected cells exposed to hypoxia for 48 h. (B) The total number of migrated
cells was counted manually. Results shown are expressed as a percentage of control invasion. *, P < 0.01. Data plotted are mean ± SD of three
separate experiments. (C) qRT-PCR results show that inhibition of HIF-1α or Notch1 signalling attenuated the up-regulation of MMP2 and MMP9
observed during hypoxia. The results normalized to β-Actin are presented as relative expression level. *, P < 0.01. Data plotted are mean ± SD of
three separate experiments. (D) Representative Western blot showing down-regulation of MMP2 and MMP9 expression by silencing HIF-1α or
Notch1 in hypoxia.
Figure 7 Hypoxia resulted in significant resistance to dexamethasone in T-ALL cells. (A) Jurkat and Sup-T1 cells were treated with 1 μM
dexamethasone in normoxic or hypoxic conditions for 48 h and subjected to Annexin V/PI staining for flow cytometry. The percentage of cells is
shown in each quadrant. (B) The hypoxia group had a lower percentage of apoptotic cells than the normoxia group by quantitative analysis. *,
P < 0.01. (C) Antiapoptotic proteins Bcl-2, Bcl-xL and cleaved caspase 9 (Cas 9), caspase 3 (Cas 3) and PARP were estimated by Western blot.
Results shown are representative of at least three independent experiments.
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Figure 8 Notch1 signalling is required for hypoxia/HIF-1α-mediated T-ALL chemoresistance. (A) HIF-1α- or Notch1 siRNA-transfected cells
were subjected to Annexin V/PI staining and flow cytometry after treatment with 1 μM dexamethasone under hypoxic conditions for 48 h. (B)
Percent of total apoptotic cells by quantitative analysis. *, P < 0.01. Down-regulation of HIF-1α or Notch1 effectively impaired cell viability in
hypoxia, with an increased proportion of apoptosis induced by dexamethasone. (C) Western blot analyses of apoptosis-related proteins with cell
lysates under the same conditions. Results shown are representative of at least three independent experiments.
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http://www.jhoonline.org/content/6/1/3an anti-leukemia drug commonly used in T-ALL treat-
ment, was acquired by T-ALL cells in response to hyp-
oxia. Under our hypoxic culture conditions (2% oxygen
tension), dexamethasone exhibited less effectiveness.
Further investigation revealed that hypoxia and HIF-1α
increased expression of Bcl-2 and Bcl-xL, leading to a
marked decrease in caspase activity.
Several studies have demonstrated the contribution of
the Notch pathway to chemoresistance in human malig-
nancies. Previous studies on solid tumors suggested that
Notch is involved in the formation of cancer stem cells
and the acquisition of the epithelial-mesenchymal transi-
tion phenotype, which are both critically associated with
chemoresistance [34,35]. In myeloma and other malignant
lymphoid cell lines, studies have demonstrated that
Notch1 is closely related to bone marrow stroma–
mediated drug resistance, and that inhibition of Notch sig-
nalling sensitizes cells to chemotherapy and prevents bonemarrow-mediated chemoresistance [36,37]. Here, we
showed that knockdown of Notch1 prevented the protect-
ive effect of hypoxia/HIF-1α against dexamethasone-
induced apoptosis. This sensitization correlated with loss
of the effect of hypoxia/HIF-1α on Bcl-2 and Bcl-xL
expression.
Rohwer et al. reported that HIF-1α suppressed gastric
cancer chemosensitivity via modulation of p53, indicating
that hypoxia-induced chemoresistance was dependent on
a functional p53 pathway [38]. Because the leukemic T-
cell lines used in our study do not have functional p53,
our results provide evidence that activation of the Notch1
pathway may represent an alternative mechanism for
hypoxia-induced chemoresistance in mutant p53 cell lines.
HIF-1α knockdown by siRNA or antisense techniques
has been shown to suppress cell growth, proliferation and
migration in both normal human cells and malignant
tumor cells, including umbilical vascular endothelial cells,
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http://www.jhoonline.org/content/6/1/3medulloblastoma, prostate cancer and glioma [39-42]. Si-
lencing HIF-1α also has been shown to reverse chemo-
therapy resistance in tumor cells [42]. Our finding, that
blocking HIF-1α sensitized T-ALL cells to dexamethasone
treatment, suggests that HIF-1α may be a potential target
for gene therapy in T-ALL cells.
Conclusions
The present study shows that, in T-ALL cells, prolifera-
tion, invasion and resistance to chemotherapy were stimu-
lated when cells were exposed to hypoxic conditions, due
in part to activation of Notch1 signalling. Moreover, we
show that in hypoxic conditions Notch1 signalling is
required to activate genes regulating cellular proliferation,
invasion and chemoresistance, increasing the aggressive-
ness of T-ALL and its likelihood for progression. Our
work is the first to characterize the interaction between
Notch1 and HIF-1α in T-ALL. These results suggest that
pharmacological inhibition of Notch1 or HIF-1α signalling
might have potential for improving T-ALL therapy.
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